Abstract: The present disclosure relates to an information processing device, an information processing method, and a program, by which a more realistic live stream of an event can be achieved. A display control unit displays, on a terminal, a plurality of viewpoint images captured at different viewpoints in an event, and an avatar information acquisition unit acquires avatar information about display of avatars corresponding to each of a user who is viewing the plurality of viewpoint images displayed on the terminal and other users who are viewing the plurality of viewpoint images on other terminals. The display control unit controls the display of the avatars based on the avatar information, for the viewpoint images displayed on the terminal. The present technique is applicable to, for example, smartphones.

Abstract: A lens holding unit is held so that it can relatively move with respect to a base part to a direction vertical to an optical axis direction. The lens holding unit has a lens holder, a magnet part, and a spring. The lens holder has a first coil. The magnet part has a first magnet part which includes a first face facing to the first coil and a second magnet part which includes a second face vertical to the first face and constitutes a magnetic domain different from that of the first magnet part. These first magnet part and second magnet part are integrated.

Abstract: A lens holding device includes a movable part having a coil attached to a lens holder holding a lens and includes a magnet part arranged around an outer peripheral side of the movable part so as to face the coil. The lens holding device includes a support part which supports the movable part so as to move relatively and a spring which connects the movable part and the support part resiliently. The magnet part includes a resin and has an alignment part which positions the spring.

Abstract: To provide a compound useful as an active ingredient of a pharmaceutical composition for treating 11?-hydroxysteroid dehydrogenase type 1-related diseases such as dementia, schizophrenia, depression, pain (particularly, neuropathic pain or fibromyalgia), diabetes (particularly, type II diabetes mellitus), insulin resistance and the like. [Means for Solution] A bicyclic heterocyclic compound (the bicyclic heterocycle is formed when a cyclohexane ring is fused with a 5- to 6-membered monocyclic heterocycle that has only a nitrogen atom as a hetero atom) substituted with an acylamino group such as a (hetero)aroylamino group or the like or a pharmaceutically acceptable salt thereof was found to have an excellent selective inhibitory action against 11?-HSD1.

Abstract: A lens holding device includes a movable part having a coil attached to a lens holder holding a lens and includes a magnet part arranged around an outer peripheral side of the movable part so as to face the coil. The lens holding device includes a support part which supports the movable part so as to move relatively and a spring which connects the movable part and the support part resiliently. The magnet part includes a resin and has an alignment part which positions the spring.

Abstract: A lens holding unit is held so that it can relatively move with respect to a base part to a direction vertical to an optical axis direction. The lens holding unit has a lens holder, a magnet part, and a spring. The lens holder has a first coil. The magnet part has a first magnet part which includes a first face facing to the first coil and a second magnet part which includes a second face vertical to the first face and constitutes a magnetic domain different from that of the first magnet part. These first magnet part and second magnet part are integrated.

Abstract: [Problem] To provide a compound useful as an active ingredient of a pharmaceutical composition for treating 11?-hydroxysteroid dehydrogenase type 1-related diseases such as dementia, schizophrenia, depression, pain (particularly, neuropathic pain or fibromyalgia), diabetes (particularly, type II diabetes mellitus), insulin resistance and the like. [Means for Solution] A bicyclic heterocyclic compound (the bicyclic heterocycle is formed when a cyclohexane ring is fused with a 5- to 6-membered monocyclic heterocycle that has only a nitrogen atom as a hetero atom) substituted with an acylamino group such as a (hetero)aroylamino group or the like or a pharmaceutically acceptable salt thereof was found to have an excellent selective inhibitory action against 11?-HSD1.

Abstract: [Problem] To provide a compound useful as medicine having PDE4B inhibitory activity, in particular, as an active ingredient of a composition for treating or preventing schizophrenia, Alzheimer's disease, dementia, depression and the like. [Measures for Solution] The present inventors examined compounds having PDE4B inhibitory activity and found that a tricyclic or tetracyclic imidazo[1,2-a]pyridine derivative or salts thereof had a superior PDE4B inhibitory activity, thereby completing the present invention. The imidazo[1,2-a]pyridine derivative can be used as an agent for treating or preventing schizophrenia, Alzheimer's disease, dementia, depression and the like.

Abstract: A lens driving apparatus has a lens portion 21, a first driving portion 36 and 37 to cause a movement of a movable unit 20 including said lens portion 21 relatively to a fixed portion 10 along a vertical direction of a light axis of said lens portion 21, a second driving portion 23 and 26 to cause a movement of said lens portion relatively to said fixed portion 10 along said light axis, an image sensor 11 held on said fixed portion 10 to detect a light which comes through said lens portion 21, an inner casing 28a held on said fixed portion 10 to cover said movable unit 20 and said image sensor 11, and a planar flexible printed circuit 50 to which a shake detection sensor 58 detecting a shake of said fixed portion 10 is connected. The planar flexible printed circuit 50 is attached to contact with a sidewall surface of said inner casing 28a parallel to the light axis of said lens.

Abstract: Anytime obtained is uniform crystal of N-(4-fluorophenyl)-N?-phenyl-N?-(pyrimidin-2-ylmethyl)-1,3,5-triazine-2,4,6-triamine (compound A) and/or N,N?-bis (4-fluorophenyl)-N?-(pyrimidin-2-ylmethyl)-1,3,5-triazine-2,4,6-triamine (compound B) as a medicament or a starting material for the preparation of the medicament, and provided are a fumarate of the compound A and/or the compound B having excellent stability and a novel crystal thereof. A salt of the compound A and/or the compound B with fumaric acid enables uniform crystal to be anytime obtained, and thus, it is a compound that is very useful as a medicament or a starting material for the preparation of the medicament having excellent stability.

Abstract: A recording and reading system for a multi-layered optical recording medium includes: a multi-layered optical recording medium including a plurality of recording layers and a single servo layer; and an optical head. The optical head includes a recording and reading objective lens of a signal recording and reading optical system and a servo objective lens of a servo signal detection optical system that are disposed on a common actuator. The recording and reading objective lens is mounted on the common actuator through a minute-drive apparatus so as to be minutely driven in a focusing direction relative to the servo objective lens. When the servo objective lens is focused on the servo layer, a reading light beam is quickly focused on a target one of the plurality of recording layers.

Abstract: [Problem] A compound, which can be used for preventing or treating diseases, in which 11?-hydroxysteroid dehydrogenase type 1 (11?-HSD1) is concerned, in particular, diabetes, insulin resistance, dementia, schizophrenia and depression, is provided. [Means for Solution] It was found that a triazole derivative, in which one of the 3- and 5-positions of the triazole ring has (di)alkylmethyl or cycloalkyl, each of which is substituted with —O— (aryl or a heterocyclic group, each of which may be substituted, or lower alkylene-cycloalkyl), and the other thereof has aryl, a heterocyclic group or cycloalkyl, each of which may be substituted, or a pharmaceutically acceptable salt thereof exhibits potent 11?-HSD1 inhibitory action. From the above, the triazole derivative of the present invention can be used for preventing or treating diabetes, insulin resistance, dementia, schizophrenia and depression.

Abstract: A compound which is useful as an active ingredient of a pharmaceutical composition for treating neuropathic pain is provided. The present inventors have made extensive studies on compounds having an FAAH inhibitory activity, and as a result, have found that an azole compound substituted with an N-(pyridine-3-yl)oxycarbonyl-piperidin-4-yl group and a phenyl group or a pharmaceutically acceptable salt thereof has an excellent FAAH inhibitory activity, thereby completing the present invention. The compound of the present invention is confirmed to have an excellent FAAH inhibitory activity and an antiallodynic effect in rat models with neuropathic pain, and thus is useful as an agent for preventing and/or an agent for treating neuropathic pain.

Abstract: An optical head device (optical head) for a multi-layered optical recording medium has a focus control mechanism that makes use of astigmatism. The focus control mechanism has a sensor lens that includes a cylindrical lens. The focus control mechanism causes a light beam having passed through the sensor lens to have astigmatism, thereby being focused linearly in the Y direction on a front focal line located closer to the sensor lens and focused linearly in the X direction at a rear focal line located farther therefrom. The optical head also includes a photodetector which is disposed between the front focal line and the rear focal line to detect a focal position from the shape of a light beam. At the position of the front focal line, a shield plate with a window portion is disposed. The window portion has a size so as to allow the focal line to pass therethrough and shield stray light reflected from an unfocused recording layer.

Abstract: A lens driving apparatus has a lens portion 21, a first driving portion 36 and 37 to cause a movement of a movable unit 20 including said lens portion 21 relatively to a fixed portion 10 along a vertical direction of a light axis of said lens portion 21, a second driving portion 23 and 26 to cause a movement of said lens portion relatively to said fixed portion 10 along said light axis, an image sensor 11 held on said fixed portion 10 to detect a light which comes through said lens portion 21, an inner casing 28a held on said fixed portion 10 to cover said movable unit 20 and said image sensor 11, and a planar flexible printed circuit 50 to which a shake detection sensor 58 detecting a shake of said fixed portion 10 is connected. The planar flexible printed circuit 50 is attached to contact with a sidewall surface of said inner casing 28a parallel to the light axis of said lens.

Abstract: A compound which is useful as an active ingredient of a pharmaceutical composition for treating neuropathic pain is provided. The present inventors have made extensive studies on compounds having an FAAH inhibitory activity, and as a result, have found that an azole compound substituted with an N-(pyridine-3-yl)oxycarbonyl-piperidin-4-yl group and a phenyl group or a pharmaceutically acceptable salt thereof has an excellent FAAH inhibitory activity, thereby completing the present invention. The compound of the present invention is confirmed to have an excellent FAAH inhibitory activity and an antiallodynic effect in rat models with neuropathic pain, and thus is useful as an agent for preventing and/or an agent for treating neuropathic pain.

Abstract: [Problem] A compound, which can be used for preventing or treating diseases, in which 11?-hydroxysteroid dehydrogenase type 1 (11?-HSD1) is concerned, in particular, diabetes, insulin resistance, dementia, schizophrenia and depression, is provided. [Means for Solution] It was found that a triazole derivative, in which one of the 3- and 5-positions of the triazole ring has (di)alkylmethyl or cycloalkyl, each of which is substituted with —O— (aryl or a heterocyclic group, each of which may be substituted, or lower alkylene-cycloalkyl), and the other thereof has aryl, a heterocyclic group or cycloalkyl, each of which may be substituted, or a pharmaceutically acceptable salt thereof exhibits potent 11?-HSD1 inhibitory action. From the above, the triazole derivative of the present invention can be used for preventing or treating diabetes, insulin resistance, dementia, schizophrenia and depression.

Abstract: Anytime obtained is uniform crystal of N-(4-fluorophenyl)-N?-phenyl-N?-(pyrimidin-2-ylmethyl)-1,3,5-triazine-2,4,6-triamine (compound A) and/or N,N?-bis (4-fluorophenyl)-N?-(pyrimidin-2-ylmethyl)-1,3,5-triazine-2,4,6-triamine (compound B) as a medicament or a starting material for the preparation of the medicament, and provided are a fumarate of the compound A and/or the compound B having excellent stability and a novel crystal thereof. A salt of the compound A and/or the compound B with fumaric acid enables uniform crystal to be anytime obtained, and thus, it is a compound that is very useful as a medicament or a starting material for the preparation of the medicament having excellent stability.

Abstract: A photodetector used in, for example, an optical pickup device includes: a photodetection unit including a plurality of photodetection elements and provided on a semiconductor chip; a light transmitting unit formed on the upper surface of the photodetection unit; and a light shielding layer having an optical aperture and disposed on the upper surface of the light transmitting unit, with these components being formed integrally. The light transmitting unit is configured such that the distance between the optical aperture and the photodetection unit is maintained constant, and the optical aperture is formed such that the inner portion of an incident light beam passes therethrough. The positioning of the photodetector and the positioning of the optical aperture such as a pinhole or a slit for adjusting the light beam entering the photodetection elements of the photodetector can be made at the same time.

Abstract: To provide a compound which has an excellent activity to modulate the functions of CCR4 or TARC and/or MDC and can be used for the prevention and/or treatment of various inflammatory diseases, allergic diseases, autoimmune diseases and the like. An acylaminopiperidine compound represented by the formula (I) or a pharmaceutically acceptable salt thereof. [Symbols in the formula represent the following meanings; A: a single bond or C1-C6 alkylene, R1: phenyl which may be substituted, etc., R2: —H or C1-C6 alkyl, R3: —H, C1-C6 alkyl or C3-C8 cycloalkyl, R4: pyrrolidin-2-yl which may be substituted, etc., and D: benzene ring or pyrazole ring].